Banner
References
NEUROLOGICAL
Malattia di Parkinson: dalla riabilitazione alla stimolazione cerebrale profonda
published in November - December 2013 - in Il Fisioterapista - issue n.6

There are no translations available.

Bibliografia

  1. Rosati G, Granieri E, Pinna L, Devoto MC. The frequency of Parkinson’s disease in the Province of Nuoro (Sardinia). Acta Neurol 1979; 1(4): 303-8.

  2. Morgante L, Rocca WA, Di Rosa AE, et al. Prevalence of Parkinson’s disease and other types of parkinsonism: a door-to-door survey in three Sicilian municipalities. The Sicilian Neuro-Epidemiologic Study (SNES) Group. Neurology 1992; 42(10): 1901-7.

  3. Rajput AH, Offord KP, Beard CM, Kurland LT. Epidemiology of parkinsonism: incidence, classification, and mortality. Ann Neurol 1984; 16(3): 278-82.

  4. Dorsey ER, Constantinescu R, Thompson JP,et al. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology 2007; 68(5): 384-6.

  5. Jellinger KA. Neuropathology of sporadic Parkinson’s disease: evaluation and changes of concepts. Mov Disord 2012; 27(1): 8-30.

  6. Jellinger K. Quantitative changes in some subcortical nuclei in aging, Alzheimer’s disease and Parkinson’s disease. Neurobiol Aging 1987; 8(6): 556-61.

  7. Braak H, Del Tredici K, Bratzke H, et al. Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson’s disease (preclinical and clinical stages). J Neurol. 2002; 249 Suppl 3:III/1-5.

  8. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967; 17(5): 427-42.

  9. Maetzler W, Liepelt I, Berg D. Progression of Parkinson’s disease in the clinical phase: potential markers. Lancet Neurol 2009 ; 8(12): 1158-71.

  10. Nutt JG, Bloem BR, Giladi N, et al. Freezing of gait: moving forward on a mysterious clinical phenomenon. Lancet Neurol 2011; 10(8): 734-44.

  11. Amboni M, Cozzolino A, Longo K, Picillo M, Barone P. Freezing of gait and executive functions in patients with Parkinson’s disease. Mov Disord 2008; 23(3): 395-400.

  12. Bloem BR, Hausdorff JM, Visser JE, Giladi N. Falls and freezing of gait in Parkinson’s disease: a review of two interconnected, episodic phenomena. Mov Disord 2004; 19(8): 871-84.

  13. Kalf JG, de Swart BJ, Bloem BR, Munneke M. Prevalence of oropharyngeal dysphagia in Parkinson’s disease: a meta-analysis. Parkinsonism Relat Disord 2012; 18(4): 311-5.

  14. Barone P, Antonini A, Colosimo C, et al. PRIAMO study group. The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson’s disease. Mov Disord 2009; 24(11): 1641-9.

  15. NICE clinical guideline. Parkinson’s disease – Diagnosis and management in primary and secondary care. 2006.

  16. Ceravolo MG. Rehabilitation goals and strategies in Parkinson’s disease. Eur J Phys Rehabil Med. 2009 Jun; 45(2): 205-8.

  17. Koplas PA, Gans HB, Wisely MP, et al. Quality of life and Parkinson’s disease. J Gerontol A Biol Sci Med Sci 1999; 54(4): M197-202.

  18. Hirsch MA, Farley BG. Exercise and neuroplasticity in persons living with Parkinson’s disease. Eur J Phys Rehabil Med 2009; 45(2): 215-29.

  19. Ahlskog JE. Does vigorous exercise have a neuroprotective effect in Parkinson disease? Neurology 2011; 77(3): 288-94.

  20. Shadmehr R, Wise SP. Computational neurobiology of reaching and pointing: a foundation for motor learning. Cambridge MA: MIT Press, 2005.

  21. Morris ME, Watts JJ, Iansek R, et al. Quantifying the profile and progression of impairments, activity, participation, and quality of life in people with Parkinson disease: protocol for a prospective cohort study. BMC Geriatr 2009; 9:2.

  22. Fisher BE, Wu AD, Salem GJ, et al. The effect of exercise training in improving motor performance and corticomotor excitability in people with early Parkinson’s disease. Arch Phys Med Rehabil 2008; 89(7): 1221-9.

  23. Agostino R, Currà A, Soldati G, et al. Prolonged practice is of scarce benefit in improving motor performance in Parkinson’s disease. Mov Disord 2004;19(11): 1285-93.

  24. Kang UJ, Auinger P; Parkinson Study Group Elldopa Investigators. Activity enhances dopaminergic long-duration response in Parkinson disease. Neurology 2012; 78(15): 1146-9.

  25. Nijkrake MJ, Keus SH, Ewalds H, et al. Quality indicators for physiotherapy in Parkinson’s disease. Eur J Phys Rehabil Med 2009 ; 45(2): 239-45.

  26. Haas CJ, Okun MS. Time for comprehensive care networks for Parkinson’s disease. Lancet Neurol 2010; 9: 20-2.

  27. Nijkrake MJ, Keus SH, Oostendorp RA, et al. Allied health care in Parkinson’s disease: referral, consultation, and professional expertise. Mov Disord 2009; 24(2): 282-6.

  28. Nieuwboer A. Cueing for freezing of gait in patients with Parkinson’s disease: a rehabilitation perspective. Mov Disord 2008; 23 Suppl 2: S475-81.

  29. Nieuwboer A, Kwakkel G, Rochester L, et al. Cueing training in the home improves gait-related mobility in Parkinson’s disease: the RESCUE trial. J Neurol Neurosurg Psychiatry 2007; 78(2): 134-40.

  30. Volpe D. Riabilitazione e malattia di Parkinson. J Neurodeg Disorders 2010; 9-17.

  31. Hirsch MA, Dulin M, Iyer SS, Hammond FM. Exercise for management and treatment of Parkinson disease. Am Fam Physician 2009; 79(12): 1043.

  32. Fox SH, Katzenschlager R, Lim SY, et al. The Movement disorder society evidence-based medicine review update: Treatments for the motor symptoms of Parkinson’s disease. Mov Disord 2011; 26 Suppl 3: S2-41.

  33. Tomlinson CL, Patel S, Meek C, et al. Physiotherapy versus placebo or no intervention in Parkinson’s disease. Cochrane Database Syst Rev 2012; 8: CD002817.

  34. Keus SH, Bloem BR, van Hilten JJ, Ashburn A, Munneke M. Effectiveness of physiotherapy in Parkinson’s disease: the feasibility of a randomised controlled trial. Parkinsonism Relat Disord 2007; 13(2): 115-21.

  35. Keus SH, Munneke M, Nijkrake MJ, Kwakkel G, Bloem BR. Physical therapy in Parkinson’s disease: evolution and future challenges. Mov Disord 2009; 24(1): 1-14.

  36. Mehrholz J, Friis R, Kugler J, et al. Treadmill training for patients with Parkinson’s disease. Cochrane Database Syst Rev 2010 Jan 20;(1): CD007830.

  37. Lee MS, Lam P, Ernst E. Effectiveness of tai chi for Parkinson’s disease: a critical review. Parkinsonism Relat Disord 2008; 14(8): 589-94.

  38. Hackney ME, Earhart GM. Effects of dance on gait and balance in Parkinson’s disease: a comparison of partnered and nonpartnered dance movement. Neurorehabil Neural Repair 2010; 24(4): 384-92.

  39. Hall E, Verheyden G, Ashburn A.Effect of a yoga programme on an individual with Parkinson’s disease: a single-subject design. Disabil Rehabil 2011; 33(15-16): 1483-9.

  40. King LA, Horak FB. Delaying mobility disability in people with Parkinson disease using a sensorimotor agility exercise program. Phys Ther 2009; 89(4): 384-93.

  41. van Eijkeren FJ, Reijmers RS, Kleinveld MJ, et al. Nordic walking improves mobility in Parkinson’s disease. Mov Disord 2008; 23(15): 2239-43.

  42. Reuter I, Mehnert S, Leone P, et al. Effects of a flexibility and relaxation programme, walking, and nordic walking on Parkinson’s disease. J Aging Res 2011; 2011: 232473

  43. Lewis MM, Slagle CG, Smith AB, et al. Task specific influences of Parkinson’s disease on the striato-thalamo-cortical and cerebello-thalamo-cortical motor circuitries. Neuroscience 2007; 147(1): 224-35.

  44. Earhart GM. Dance as therapy for individuals with Parkinson disease. Eur J Phys Rehabil Med 2009; 45(2): 231-8.

  45. de Dreu MJ, van der Wilk AS, Poppe E, Kwakkel G, van Wegen EE. Rehabilitation, exercise therapy and music in patients with Parkinson’s disease: a meta-analysis of the effects of music-based movement therapy on walking ability, balance and quality of life. Parkinsonism Relat Disord 2012; 18 Suppl 1: S114-9.

  46. Trend P, Kaye J, Gage H, Owen C, Wade D. Short-term effectiveness of intensive multidisciplinary rehabilitation for people with Parkinson’s disease and their carers. Clin Rehabil 2002; 16(7): 717-25.

  47. Pitts T, Bolser D, Rosenbek J, et al. Impact of expiratory muscle strength training on voluntary cough and swallow function in Parkinson disease. Chest 2009; 135(5): 1301-8.

  48. Herd CP, Tomlinson CL, Deane KH, et al. Comparison of speech and language therapy techniques for speech problems in Parkinson’s disease. Cochrane Database Syst Rev 2012; 8: CD002814.

  49. Herd CP, Tomlinson CL, Deane KH, et al. Speech and language therapy versus placebo or no intervention for speech problems in Parkinson’s disease Cochrane Database Syst Rev 2012; 8: CD002812.

  50. Lang AE, Houeto JL, Krack P, et al. Deep brain stimulation: preoperative issues. Mov Disord 2006; 21 Suppl 14: S171-96.

  51. Wächter T, Mínguez-Castellanos A, Valldeoriola F, Herzog J, Stoevelaar H. A tool to improve pre-selection for deep brain stimulation in patients with Parkinson’s disease. J Neurol 2011; 258(4): 641-6.

  52. Schuepbach WM, Rau J, Knudsen K, et al.; EARLYSTIM Study Group. Neurostimulation for Parkinson’s disease with early motor complications. N Engl J Med 2013; 368(7): 610-22.

  53. Follett KA, Torres-Russotto D. Deep brain stimulation of globus pallidus interna, subthalamic nucleus, and pedunculopontine nucleus for Parkinson’s disease: which target? Parkinsonism Relat Disord 2012; 18 Suppl 1: S165-7.

  54. Follett KA, Weaver FM, Stern M, et al.; CSP 468 Study Group. Pallidal versus subthalamic deep-brain stimulation for Parkinson’s disease. N Engl J Med 2010; 362(22): 2077-91.

  55. Odekerken VJ, van Laar T, Staal MJ, et al. Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson’s disease (NSTAPS study): a randomised controlled trial. Lancet Neurol 2013; 12(1): 37-44.

  56. Capecci M, Ricciuti RA, Burini D, et al. Functional improvement after subthalamic stimulation in Parkinson’s disease: a non-equivalent controlled study with 12-24 month follow up. J Neurol Neurosurg Psychiatry 2005; 76(6): 769-74.

  57. Morgante L, Morgante F, Moro E, et al. How many parkinsonian patients are suitable candidates for deep brain stimulation of subthalamic nucleus? Results of a questionnaire. Parkinsonism Relat Disord 2007; 13(8): 528-31.

  58. Daniels C, Krack P, Volkmann J, et al. Is improvement in the quality of life after subthalamic nucleus stimulation in Parkinson’s disease predictable? Mov Disord 2011; 26(14): 2516-21.

  59. Tan D, Danoudis M, McGinley J, Morris ME. Relationships between motor aspects of gait impairments and activity limitations in people with Parkinson’s disease: a systematic review. Parkinsonism Relat Disord 2012; 18(2): 117-24.

  60. Zibetti M, Merola A, Rizzi L, et al. Beyond nine years of continuous subthalamic nucleus deep brain stimulation in Parkinson’s disease. Mov Disord 2011; 26(13): 2327-34.

  61. Merola A, Zibetti M, Angrisano S, et al. Parkinson’s disease progression at 30 years: a study of subthalamic deep brain-stimulated patients. Brain 2011; 134(Pt 7): 2074-84.

  62. Deuschl G, Jan Herzog, Galit Kleiner-Fisman, et al. Deep brain stimulation: postoperative issues. Movement Disorders 2006; 21 (Suppl. 14): S219–37.

  63. van Nimwegen M, Speelman AD, Hofman-van Rossum EJ, et al. Physical inactivity in Parkinson’s disease. J Neurol 2011; 258(12): 2214-21.

  64. Ellis T, Cavanaugh JT, Earhart GM, et al. Factors associated with exercise behavior in people with Parkinson disease. Phys Ther 2011; 91(12): 1838-48.

  65. Ceravolo MG, Paoloni L, Provinciali L. Rehabilitation of parkinsonian patients. Funct Neurol 2001; 16(2): 157-62.

  66. Castelli L, Lanotte M, Zibetti M, et al. Apathy and verbal fluency in STN-stimulated PD patients. An observational follow-up study. J Neurol 2007; 254(9): 1238-43.

  67. Cohen DB, Oh MY, Baser SM, et al. Fast-track programming and rehabilitation model: a novel approach to postoperative deep brain stimulation patient care. Arch Phys Med Rehabil 2007; 88(10): 1320-4.

  68. Tassorelli C, Buscone S, Sandrini G,et al. The role of rehabilitation in deep brain stimulation of the subthalamic nucleus for Parkinson’s disease: a pilot study. Parkinsonism Relat Disord 2009; 15(9): 675-81

  69. Skodda S. Effect of deep brain stimulation on speech performance in Parkinson’s disease. Parkinsons Dis 2012; 2012: 850596.

  70. Sapir S, Ramig LO, Fox CM. Intensive voice treatment in Parkinson’s disease: Lee Silverman Voice Treatment. Expert Rev Neurother 2011; 11(6): 815-30.

  71. Spielman J, Mahler L, Halpern A, et al. Intensive voice treatment (LSVT®LOUD) for Parkinson’s disease following deep brain stimulation of the subthalamic nucleus. J Commun Disord 2011; 44(6): 688-700

  72. Tripoliti E, Strong L, Hickey F, et al. Treatment of dysarthria following subthalamic nucleus deep brain stimulation for Parkinson’s disease. Mov Disord 2011; 26(13): 2434-6.

  73. Nazzaro JM, Pahwa R, Lyons KE. The impact of bilateral subthalamic stimulation on non-motor symptoms of Parkinson’s disease. Parkinsonism Relat Disord 2011; 17(8): 606-9.

  74. Volpe D, Sentari A, Letrtieri C, Biguzzi S, Eleopra R. Rehabilitation on gait in Parkinson’s disease with deep brain stimulation. Mov Dis 2008; 23 (S1): 205.


 
There are no translations available.